242 PARP-inhibitors beyond progression: a new way to manage oligometastatic ovarian cancer recurrence | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Ovarian cancer

242 PARP-inhibitors beyond progression: a new way to manage oligometastatic ovarian cancer recurrence

Free

Online download statistics by month:

Online download statistics by month: October 2021 to March 2023

	Abstract	Full	Pdf
Oct 2021	48	0	9
Nov 2021	41	0	9
Dec 2021	21	0	2
Jan 2022	40	0	8
Feb 2022	67	0	3
Mar 2022	92	0	30
Apr 2022	28	0	6
May 2022	30	0	22
Jun 2022	72	0	22
Jul 2022	36	0	4
Aug 2022	38	0	9
Sep 2022	26	0	12
Oct 2022	58	0	15
Nov 2022	34	0	13
Dec 2022	20	0	5
Jan 2023	41	0	13
Feb 2023	18	0	2
Mar 2023	7	0	1
Total	717	0	185